Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$90.44 Million ≈ $2.85 Million USD) by net assets (NT$3.18 Billion ≈ $100.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chunghwa Chemical Synthesis & Biotech Co (1762) liquidity interval to measure how many days the company can operate on defensive assets alone.

Chunghwa Chemical Synthesis & Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pelthos Therapeutics Inc. NYSE MKT:PTHS	-0.161x
Billion Electric Co Ltd TW:3027	0.026x
Rimoni TA:RIMO	0.063x
Dilli Illustrate Inc KQ:131180	-0.020x
Pearson PLC LSE:PSON	0.129x
Munsin Garment TWO:2916	-0.053x
Téléverbier SA PA:TVRB	0.232x
Lionsgate Studios Holding Corp. (to be renamed Lionsgate Studios Corp.) NASDAQ:LION	0.172x

Annual Cash Flow Conversion Efficiency for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 1762 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$3.09 Billion ≈ $97.27 Million	NT$142.61 Million ≈ $4.49 Million	0.046x	-66.84%
2024-12-31	NT$3.36 Billion ≈ $105.76 Million	NT$467.65 Million ≈ $14.73 Million	0.139x	+702.20%
2023-12-31	NT$3.35 Billion ≈ $105.55 Million	NT$-77.50 Million ≈ $-2.44 Million	-0.023x	-110.07%
2022-12-31	NT$3.19 Billion ≈ $100.60 Million	NT$733.78 Million ≈ $23.12 Million	0.230x	+203.46%
2021-12-31	NT$2.89 Billion ≈ $91.19 Million	NT$219.18 Million ≈ $6.91 Million	0.076x	+36.88%
2020-12-31	NT$2.50 Billion ≈ $78.72 Million	NT$138.24 Million ≈ $4.36 Million	0.055x	-58.42%
2019-12-31	NT$2.02 Billion ≈ $63.49 Million	NT$268.13 Million ≈ $8.45 Million	0.133x	+12.49%
2018-12-31	NT$1.98 Billion ≈ $62.50 Million	NT$234.66 Million ≈ $7.39 Million	0.118x	+35.20%
2017-12-31	NT$1.82 Billion ≈ $57.38 Million	NT$159.34 Million ≈ $5.02 Million	0.087x	-40.70%
2016-12-31	NT$1.77 Billion ≈ $55.80 Million	NT$261.31 Million ≈ $8.23 Million	0.148x	+245.00%
2015-12-31	NT$1.86 Billion ≈ $58.72 Million	NT$79.70 Million ≈ $2.51 Million	0.043x	+199.40%
2014-12-31	NT$1.62 Billion ≈ $50.91 Million	NT$23.08 Million ≈ $727.18K	0.014x	-83.17%
2013-12-31	NT$1.71 Billion ≈ $53.91 Million	NT$145.24 Million ≈ $4.58 Million	0.085x	-47.02%
2012-12-31	NT$1.68 Billion ≈ $52.79 Million	NT$268.46 Million ≈ $8.46 Million	0.160x	+85.46%
2011-12-31	NT$1.68 Billion ≈ $52.82 Million	NT$144.84 Million ≈ $4.56 Million	0.086x	-47.25%
2010-12-31	NT$1.68 Billion ≈ $53.01 Million	NT$275.61 Million ≈ $8.68 Million	0.164x	-57.67%
2009-12-31	NT$1.19 Billion ≈ $37.63 Million	NT$462.07 Million ≈ $14.56 Million	0.387x	+329.84%
2008-12-31	NT$837.53 Million ≈ $26.39 Million	NT$75.39 Million ≈ $2.38 Million	0.090x	--

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology

Market Cap

$85.54 Million

NT$2.72 Billion TWD

Market Cap Rank

#19883 Global

#1172 in Taiwan

Share Price

NT$35.30

Change (1 day)

+1.73%

52-Week Range

NT$24.30 - NT$42.30

All Time High

NT$102.50